Alveolar Rhabdomyosarcoma
📧 Sign up to get email alerts when something new happens for Alveolar Rhabdomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Clinical trial update reporting Phase 1/2 results for Elimusertib in relapsed or refractory solid tumors, including alveolar rhabdomyosarcom…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma [Phase 3]
Phase 3 trial evaluating adding temsirolimus to combination chemotherapy for intermediate-risk rhabdomyosarcoma; results posted in 2024 and …
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma [Phase 3]
Phase 3 trial examining combination chemotherapy with or without temsirolimus in intermediate-risk rhabdomyosarcoma; active/not recruiting w…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: CREATE: Cross-tumoral Phase 2 With Crizotinib [Phase 2]
Phase 2 cross-tumor trial evaluating crizotinib in multiple locally advanced or metastatic cancers; study completed.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma [Phase 1, Phase 2]
A phase 1/2 trial evaluating ganitumab (IGF-1R antibody) with dasatinib (SFK inhibitor) in embryonal and alveolar rhabdomyosarcoma was termi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma [Phase 2]
A Phase 2 trial evaluated temozolomide in combination with cixutumumab and chemotherapy for metastatic rhabdomyosarcoma; the study has compl…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
The Children's Oncology Group completed a trial update analyzing biomarkers in tumor tissue from younger patients with rhabdomyosarcoma, inc…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma
A clinical trial examining protein expression in tissue samples from younger patients with alveolar rhabdomyosarcoma and embryonal rhabdomyo…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma [Phase 2]
This ClinicalTrials.gov update describes a Phase 2 pediatric trial comparing chemotherapy regimens for relapsed or progressive rhabdomyosarc…